The worldwide incidence of placenta accreta spectrum (PAS) is rapidly increasing, following
the trend of rising cesarean delivery. PAS is an heterogeneous condition associated with a …

The terminology and diagnostic criteria presently used by pathologists to report invasive
placentation is inconsistent and does not reflect current knowledge of the pathogenesis of …

Background Although an infrequent occurrence, the placenta can adhere abnormally to the
gravid uterus leading to significantly high maternal morbidity and mortality during cesarean …

Objective To describe the use of surgical repair (One-step resective-conservative surgery) in
all cases of placenta accreta spectrum. Study design Multicentre retrospective case series …

Introduction Placenta accreta spectrum (PAS) is a serious condition with a mortality as high
as 7%. However, the factors associated with this type of death have not been adequately …

The evolution of multidisciplinary team-based care for women with placenta accreta
spectrum disorder has delivered stepwise improvements in clinical outcomes. Central to this …

BACKGROUND There are 3 treatment options for placenta accreta spectrum: cesarean
delivery with hysterectomy, expectant management, and uterine-sparing surgical …

Increasing evidence suggests a relationship between in vitro fertilization-embryo transfer
(IVF-ET) and placenta accreta spectrum (PAS). Some studies have reported a lower rate of …

The invasion of the uterine wall by extravillous trophoblast is acknowledged as a crucial
component of the establishment of pregnancy however, the only part of this process that has …

Placenta accreta spectrum (PAS) is a high-risk obstetrical condition associated with
significant morbidity and mortality. Current clinical screening modalities for PAS are not …